Cardiopulmonary Testing for Potential Pancreas Transplant Candidates

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 14, 2024

Study Completion Date

September 14, 2024

Conditions
Cardiovascular Risk FactorDiabetes Mellitus, Type 1Pancreas Transplant; Complications
Interventions
DIAGNOSTIC_TEST

Cardiopulmonary exercise test (CPET)

"The participant will undergo a cardio-pulmonary exercise test (CPET) on a cycle ergometer (Ergoline) connected to a 12-lead electrocardiogram, oxygen saturation monitor and continuous non-invasive blood pressure cuff. Respiratory gas exchanged will be measured from a tight fitting facemask. An initial 2-min period of baseline data will be collected at rest before a 180-s period of unloaded cycling. A ramp protocol will then be applied and the participant will be instructed to continue cycling at a constant cadence of 60 rpm as long as they can. The test will be terminated if the participant indicates that:~* they cannot continue~* cadence falls to \<55 rpm due to fatigue or dyspnoea~* they develop abnormal cardiac signs or symptoms, such as ischaemia and arrhythmia."

Trial Locations (1)

Unknown

Churchill Hospital, Oxford

All Listed Sponsors
lead

Oxford University Hospitals NHS Trust

OTHER

NCT04312802 - Cardiopulmonary Testing for Potential Pancreas Transplant Candidates | Biotech Hunter | Biotech Hunter